Long term follow-up of superficial invasive bladder carcinoma with or without concomitant epithelial atypia - Recurrence and progression

被引:11
|
作者
Zieger, K
Olsen, PR
Wolf, H
Hojgaard, K
机构
[1] Aarhus Univ Hosp, Dept Urol, Skejby, Denmark
[2] Holbaek Cent Hosp, Dept Gen Surg, Hvidovre, Denmark
[3] Copenhagen Univ Hosp, Dept Pathol, Hvidovre, Denmark
来源
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY | 2002年 / 36卷 / 01期
关键词
bladder neoplasms; carcinoma-in-situ; epithelium-pathology; neoplasm recurrence; disease-progession; follow-up studies;
D O I
10.1080/003655902317259373
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To examine the significance of concomitant epithelial atypia on late recurrence and progression by long-term follow-up of superficial invasive bladder tumours (stage T1). Material and Methods: Seventy consecutive, unselected patients with newly diagnosed transurethral resection (TURB)-treated stage T1 bladder tumour, and at least 1 year progression-free survival. Preselected site biopsies (PSB) were obtained prospectively to evaluate the significance of concomitant urothelial atypia. Followed for up to 17.6 years. Results: The cumulative probability of recurrence (overall) was 85%, and for new stage T1 tumour 70% after 10 years. Forty per cent of those who survived 5 years without recurrence, were readmitted with often invasive recurrence later. Positive PSB significantly (p < 0.0001) predicted new T1 tumour. Progression (T2 + or metastases) occurred in 27 cases (39%) after the first year. The cumulative probability was 60% (15 years), with a mean progression-free interval of 64 months. Positive PSB, size >3 cm and early recurrence were significant predictive factors in multivariate analysis. Conclusion: T1-tumours are at high risk for late invasive recurrence and progression, especially if associated with urothelial atypia elsewhere in the bladder.
引用
收藏
页码:52 / 59
页数:8
相关论文
共 20 条
  • [1] Recurrence, Progression, and Follow-Up in Non-Muscle-Invasive Bladder Cancer
    van der Heijden, Antoine G.
    Witjes, J. Alfred
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (07) : 556 - 562
  • [2] S-phase fraction in superficial urothelial carcinoma of the bladder - A prospective, long-term, follow-up study
    Falkman, K
    Tribukait, B
    Nyman, CR
    Larsson, P
    Norming, U
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2004, 38 (04): : 278 - 284
  • [3] Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ
    Sakai, Iori
    Miyake, Hideaki
    Harada, Ken-Ichi
    Hara, Isao
    Inoue, Taka-Aki
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF UROLOGY, 2006, 13 (11) : 1389 - 1392
  • [4] Keyhole limpet hemocyanin for carcinoma in situ of the bladder: A long-term follow-up study
    Jurincic-Winkler, CD
    Metz, KA
    Beuth, J
    Klippel, KF
    EUROPEAN UROLOGY, 2000, 37 : 45 - 49
  • [5] LATE INVASIVE RECURRENCE DESPITE LONG-TERM SURVEILLANCE FOR SUPERFICIAL BLADDER-CANCER
    THOMPSON, RA
    CAMPBELL, EW
    KRAMER, HC
    JACOBS, SC
    NASLUND, MJ
    JOURNAL OF UROLOGY, 1993, 149 (05) : 1010 - 1011
  • [6] Long-term follow-up study of gastric intraepithelial neoplasias: progression from low-grade dysplasia to invasive carcinoma
    Park, Soo Young
    Jeon, Seong Woo
    Jung, Min Kyu
    Cho, Chang Min
    Tak, Won Young
    Kweon, Young Oh
    Kim, Sung Kook
    Choi, Yong Hwan
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (10) : 966 - 970
  • [7] Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: pure versus non-pure CIS
    Hurle, Rodolfo
    Lazzeri, Massimo
    Saita, Alberto
    Naselli, Angelo
    Guarneri, Andrea
    Buffi, Nicolo M.
    Lughezzani, Giovanni
    Fasulo, Vittorio
    Mondellini, Giulio M.
    Paciotti, Marco
    Domanico, Luigi
    Peschechera, Roberto
    Benetti, Alessio
    Zandegiacomo, Silvia
    Lista, Giuliana
    Pasini, Luisa
    Guazzoni, Giorgio
    Casale, Paolo
    MINERVA UROLOGICA E NEFROLOGICA, 2019, 71 (04) : 406 - 412
  • [8] NEOADJUVANT CISPLATIN, METHOTREXATE AND VINBLASTINE FOR MUSCLE-INVASIVE BLADDER-CANCER - LONG-TERM FOLLOW-UP
    DREICER, R
    KOLLMORGEN, TA
    SMITH, RF
    WILLIAMS, RD
    JOURNAL OF UROLOGY, 1993, 150 (03) : 849 - 852
  • [9] Long-term Recurrence and Progression Patterns in a Contemporary Series of Patients with Carcinoma In Situ of the Bladder With or Without Associated Ta/T1 Disease Treated with Bacillus Calmette-Guerin: Implications for Risk-adapted Follow-up
    Subiela, Jose Daniel
    Faba, Oscar Rodriguez
    Aumatell, Julia
    Gonzalez-Padilla, Daniel Antonio
    Bordes, Antonio Rosales
    Huguet, Jorge
    Krajewski, Wojciech
    Algaba, Ferran
    Curtis, David Lopez
    Burgos, Jennifer Brasero
    Gonzalez, Alvaro Sanchez
    Cidre, Miguel Angel Jimenez
    Revilla, Francisco Javier Burgos
    Breda, Alberto
    Palou, Joan
    EUROPEAN UROLOGY FOCUS, 2023, 9 (02): : 325 - 332
  • [10] Superficial bladder carcinoma treated with bacillus Calmette-Guerin: Progression-free and disease specific survival with minimum 10-year follow-up
    Davis, JW
    Sheth, SI
    Doviak, MJ
    Schellhammer, PF
    JOURNAL OF UROLOGY, 2002, 167 (02) : 494 - 500